NCT04923607View on ClinicalTrials.gov

Phase I Clinical Trial of TQC2731 Injection

PHASE1UnknownINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

June 25, 2021

Primary Completion Date

August 25, 2023

Study Completion Date

August 25, 2023

Conditions
Asthma Severe Persistent Controlled
Interventions
DRUG

TQC2731

TQC2731 injection

DRUG

Placebo

Matching placebo with no active ingredients

Trial Locations (1)

450052

First Affiliated Hospital of Zhengzhou University, Henan

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY